title: MYC in DLBCL: partners matter.
abstract: In this issue of Blood, Copie-Bergman et al demonstrate that MYC rearrangements (MYC-Rs) with IG genes, but not with other partner genes, have a negative prognostic impact in patients with diffuse large B-cell lymphomas (DLBCLs) treated with immunochemotherapy.
authors.affiliation: UNIVERSITY OF BARCELONA.
authors.forename: Elias
authors.identifier: http://orcid.org/0000-0001-9850-9793
authors.initials: E
authors.lastname: Campo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D007136:Immunoglobulins; D016403:Lymphoma, Large B-Cell, Diffuse; D008297:Male; D016271:Proto-Oncogene Proteins c-myc; D014178:Translocation, Genetic
chemical_list: D007136:Immunoglobulins; D016271:Proto-Oncogene Proteins c-myc